What Dr. Korman Laboratories does

Dr. Korman Laboratories Ltd. is a privately held Israeli manufacturer of injectable aesthetic medicine products headquartered in Kiryat Bialik, founded in 2010 by Dr. Svetlana Korman and Michael Gelman. The company develops, manufactures, and distributes a four-line portfolio spanning cross-linked hyaluronic acid dermal fillers (8–26 mg/ml HA), HA-based biorevitalization products with glycerol (4–10 mg/ml), mesotherapy cocktails for face and body indications, and calcium hydroxyapatite dermal implants. Core technology centers on proprietary BDDE cross-linking of non-animal origin hyaluronic acid dissolved in phosphate buffer, produced in-house with dedicated R&D and quality control functions.

The firm operates a B2B enterprise field-sales model, selling directly to dermatologists, aesthetic physicians, and medical spas in over 50 countries, supplemented by exclusive regional distribution partners — LuMed Trading Ltd. in China and Emplig Ltd. in Russia. Revenue is generated through one-time product sales with no public pricing, and there is no disclosed subscription, SaaS, or licensing layer. The company is bootstrapped with no institutional funding rounds disclosed, supports marketing through LinkedIn, Facebook, Instagram, and its corporate website, and reports a headcount in the 51–100 range.

Operationally, DKL emphasizes in-house manufacturing and R&D as core differentiators, with stated compliance to international standards enabling cross-border distribution of sterile injectable medical devices. The company also references intra-articular applications alongside aesthetic uses, suggesting an under-exploited adjacent vertical. There is no disclosed use of AI/ML technology; the intellectual property base is chemical and process-based rather than data-driven.

Name

Dr. Korman Laboratories

Legal name

Dr. Korman Laboratories Ltd.

Website

https://drkorman.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Dr. Korman Laboratories is an Israeli manufacturer of injectable aesthetic medicine products — including HA dermal fillers, biorevitalization, mesotherapy, and calcium hydroxyapatite implants — sold B2B to dermatologists and aesthetic clinics in over 50 countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Qiryat Bialik

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Aesthetic Medical Products Sales: Sale of dermal fillers, biorevitalization, mesotherapy, and calcium hydroxyapatite products to healthcare practitioners and aesthetic clinics worldwide. Revenue is generated through direct product sales and regional distribution partners.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Dr. Korman Laboratories manufactures and supplies injectable aesthetic medicine products, including cross-linked hyaluronic acid dermal fillers (8–26 mg/ml), biorevitalization skin rejuvenation products (4–10 mg/ml HA with Glycerol), mesotherapy cocktails, and calcium hydroxyapatite dermal implants. Products are sold to healthcare practitioners and aesthetic clinics in over 50 countries worldwide.

Product overview

Dr. Korman Laboratories is an aesthetic medicine company offering a portfolio of injectable dermal products. The core product line includes Dermal Fillers (cross-linked hyaluronic acid gel, 8-26 mg/ml HA), Biorevitalization (HA-based skin rejuvenation, 4-10 mg/ml with Glycerol), Mesotherapy (vitamin/antioxidant cocktails for face and body), and Calcium Hydroxyapatite dermal implants. The company operates in aesthetic medicine and intra-articular applications, selling products in over 50 countries worldwide since its founding in 2010.

Differentiator

Problem solved

Functional benefit

Products and services

• Dermal Fillers Sterile injectable pyrogen-free gel composed of cross-linked hyaluronic acid from non-animal origin, cross-linked by BDDE molecule. HA concentrations range from 8 to 26 mg/ml, used by dermatologists, aesthetic physicians, and medical professionals for facial contouring, wrinkle reduction, lip enhancement, and facial feature definition.
• Biorevitalization Hyaluronic Acid-based products for skin rejuvenation with HA concentrations ranging from 4 mg/ml to 10 mg/ml, with the addition of Glycerol, aimed at improving skin appearance with high patient satisfaction.
• Mesotherapy Non-surgical cosmetic medicine treatment that infuses the dermal layer with vitamins and antioxidants to rejuvenate skin. Includes Anti-cellulite, Hair treatment, Amino balance, and Anti-acne formulas for face and body.
• Calcium Hydroxyapatite Sterile and biodegradable dermal implants designed to define and enhance facial features. Intended for sub-dermal and deep dermal use.

Quantifiable outcome

• Products used in over 50 countries with high patient satisfaction
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• LuMed Trading Ltd.coreChannel Partner/ Reseller/ DistributorLuMed Trading Ltd. is Dr. Korman Laboratories' exclusive partner in China. The partnership enables distribution and sales of Dr. Korman Laboratories aesthetic products in the Chinese market through their website www.i-lumed.com.
• Emplig Ltd.coreChannel Partner/ Reseller/ DistributorEmplig Ltd. is Dr. Korman Laboratories' partner in Russia. The partnership manages distribution and sales of Dr. Korman Laboratories products in the Russian market through their website www.drkorman.ru.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Revance Therapeutics: Aesthetic and therapeutic company behind the RHA Collection of resilient HA fillers and DaxibotulinumtoxinA. Comparable as a next-generation HA injectable manufacturer targeting the same dermatology and aesthetic clinic customer base.
• Medytox: South Korean biopharmaceutical company producing botulinum toxin and HA fillers (Neuramis). Comparable as a manufacturer of HA-based aesthetic injectables expanding into international markets.
• Hugel (Letybo): South Korean aesthetics manufacturer producing botulinum toxin (Letybo) and HA dermal fillers. Comparable as an international injectables company expanding global distribution beyond its home market.
• LG Chem Life Sciences (Yvoire): South Korean chemical/pharma group producing the Yvoire HA dermal filler line and expanding in aesthetics. Comparable as an HA injectable manufacturer targeting global aesthetic medicine markets, with broader corporate resources than Dr. Korman.

Broad incumbents

• Allergan Aesthetics (AbbVie): Maker of Juvederm, the market-leading HA dermal filler portfolio, plus Botox and CoolSculpting. Direct competitor in aesthetic injectables with far greater scale, brand recognition, and clinical evidence.
• Merz Aesthetics: Manufacturer of Belotero (HA dermal filler), Radiesse (calcium hydroxyapatite filler), and Ultherapy. Direct competitor across DKL's core injectable categories, particularly CaHA-based products.
• Galderma: Global dermatology leader and maker of Restylane, one of the most recognized HA dermal filler brands. Directly comparable to Dr. Korman as a manufacturer of HA-based injectables serving dermatologists and aesthetic practitioners worldwide.

Direct peers

• Teoxane: Swiss-based manufacturer of premium HA dermal fillers (Teosyal range) sold internationally to aesthetic practitioners. Closely comparable mid-size pure-play HA filler company with global distribution similar to Dr. Korman.
• Croma-Pharma: Austrian manufacturer of HA-based dermal fillers, PRP kits, and biostimulators distributed across more than 80 countries. Closely comparable as a privately held European injectable aesthetics manufacturer with a multi-product portfolio and broad international reach.
• Sinclair Pharma (now under HUYGENT Biotech): Specialty aesthetics company with HA fillers (MaiLi) and collagen-stimulating injectables (Ellansé). Comparable mid-size European aesthetics manufacturer with diversified injectable portfolio targeting aesthetic practitioners.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/drkorman.ru
• Instagraminstagram.com/dr.kormanlaboratories

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr. Korman Laboratories